Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41004 Formulations in Mild to Moderate Plaque Psoriasis
NCT02111499Phase 2Completed
- Sponsor
- Almirall
- Start
- Mar 2014
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene, betamethasone dipropionate spray 0.05% in plaque psoriasis, sponsored by Almirall. Started Mar 2014; status: completed.
02
Drugs
bexarotenebetamethasone dipropionate spray 0.05%
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02111499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111499.